Healthcare (Prescription Drugs)

HB 1143 allows students with diabetes to possess and self-administer nasal glucagon (a medication for severe low blood sugar) on school property or at school events. It directly affects students diagnosed with diabetes who require this specific treatment. The bill requires a licensed healthcare provider’s diagnosis, written parent authorization, and a physician’s statement detailing the medication’s purpose, dosage, and administration guidelines to be kept on file at the school. Schools must maintain these documents in the student’s health record or with the school nurse. This change expands existing provisions for asthma and anaphylaxis medications to include nasal glucagon for diabetes management.

HB 1085 requires South Dakota health insurers to cover nonopioid prescription drugs for pain treatment when prescribed by a doctor, without denying coverage in favor of opioids. Insurers cannot impose stricter approval steps (like prior authorization) or higher cost-sharing tiers for nonopioid drugs compared to opioids or narcotics. This directly affects patients seeking pain management and insurers operating in South Dakota, ensuring equal coverage treatment for nonopioid options when clinically appropriate. The law applies to all health insurance policies sold or renewed in the state.